| Compound Information | SONAR Target prediction | | Name: | EPIANDROSTANEDIOL | | Unique Identifier: | SPE00107093 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | C19H32O2 | | Molecular Weight: | 261.21 g/mol | | X log p: | -0.0960000000000001 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 0 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 2 | | Rotatable Bond Count: | 0 | | Canonical Smiles: | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O | | Source: | ex numerous mammalian tissues | | Therapeutics: | regulation of puberty in females | | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Drug_type: | Experimental | | Drugbank_id: | EXPT00530 | | Logp: | 3.73 | | Drug_category: | Sex Hormone-Binding Globulin inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
BCK1 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.4801±0.00282843 |
| Normalized OD Score: sc h |
0.7213±0.000999504 |
| Z-Score: |
-5.4479±0.115872 |
| p-Value: |
0.0000000562834 |
| Z-Factor: |
0.632361 |
| Fitness Defect: |
16.6929 |
| Bioactivity Statement: |
Active |
| Experimental Conditions | | | Library: | Spectrum | | Plate Number and Position: | 2|G7 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 24.50 Celcius | | Date: | 2006-03-24 YYYY-MM-DD | | Plate CH Control (+): | 0.038675±0.00123 | | Plate DMSO Control (-): | 0.6602250000000001±0.02150 | | Plate Z-Factor: | 0.9014 |
|  png
ps
pdf |
| 957 |
octan-1-ol |
| 1107 |
2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| 1213 |
4,8a-dimethyldecalin-4a-ol |
| 1254 |
5-methyl-2-propan-2-yl-cyclohexan-1-ol |
| 2682 |
hexadecan-1-ol |
| 3240 |
10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a
]phenanthren-3-ol |
| active | Cluster 12674 | Additional Members: 6 | Rows returned: 4 | |
|
